AFM
NERV icon

Anson Funds Management’s Minerva Neurosciences NERV Stock Holding History

Anson Funds Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,692
Closed -$163K – 285
2020
Q4 		$163K Buy
+8,692
New +$219K 0.03% 158

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Anson Funds Management's NERV Position: Q1 2021 in Review

Anson Funds Management sold out of Minerva Neurosciences (NERV) in Q1 2021, closing a stake of 8,692 shares — an estimated $163K sold.

Anson Funds Management first reported a position in NERV in Q4 2020 and held it in 1 quarter. The position peaked at $163K in Q4 2020. 72 funds tracked by Wall St. Rank hold NERV as of Q1 2021.

  • Anson Funds Management reported no remaining Minerva Neurosciences position as of Q1 2021 after selling out during the quarter.
  • Anson Funds Management sold 8,692 Minerva Neurosciences shares in Q1 2021, an estimated $163K.
  • Anson Funds Management first reported a position in Minerva Neurosciences in Q4 2020 and held it in 1 quarter.
  • Anson Funds Management's Minerva Neurosciences position peaked at $163K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.